
Top Story
Alibaba Pays $600M Over Drug Sales Probe
Alibaba and its US payment processor will pay $600 million after US authorities said the companies failed to stop illegal drug-related sales.
Read nowNews Desk
Daily stories tuned for enthusiasts and casual readers alike. High-context, low-jargon, fast to scan.
294 articles

Top Story
Alibaba and its US payment processor will pay $600 million after US authorities said the companies failed to stop illegal drug-related sales.
Read now
Families of Venezuelans deported from the US are searching for loved ones after twin earthquakes struck hours after their flight landed.

The FBI reportedly determined that alleged ransom notes sent to media outlets in the Nancy Guthrie case are fake, though the agency has not explained how.

Melat Kiros defeated 15-term Representative Diana DeGette in a Denver-area Democratic primary, while Colorado voters also chose Phil Weiser and Manny Rutinel in key races.

Pakistan says it intercepted four drones launched from Afghanistan, while the Taliban government claims it struck targets inside Pakistan.

Donald Trump’s 2025 financial disclosure lists more than $1bn in crypto income, alongside real estate revenue, branded products and legal settlements.

Rita Seymour says she felt like a “criminal” after a dispute at her local Sainsbury’s led to a nationwide ban from Sainsbury’s and Argos stores.

Keir Starmer says Britain will spend almost £300bn over four years on defence, including more than £5bn for drones and autonomous systems.

The Supreme Court blocked Donald Trump’s order targeting birthright citizenship, keeping constitutional protections for children born in the US.

Rescue teams in Venezuela are using dogs, listening devices, cameras, drones and heavy machinery to find survivors after deadly twin earthquakes.

The Supreme Court declined to hear Donald Trump’s appeal, leaving intact the $5 million verdict awarded to writer E Jean Carroll.

A 412-page OMB proposal would give political appointees sweeping power over federal grants, alarming scientists and public program advocates.